Microbial diversity and composition in different gut locations of hyperlipidemic mice receiving krill oil

Applied Microbiology and Biotechnology

Volumn 102, Issue 1, 2018, Pages 355-366

  Lu, Chenyang ^a   Sun, Tingting ^a   Li, Yanyan ^b   Zhang, Dijun ^a   Zhou, Jun ^a   Su, Xiurong ^a  

^a NINGBO UNIVERSITY   (China)

^b Cornell University ^*  (United States)

Author keywords

16S rRNA sequencing; Gastrointestinal tract; Hyperlipidemia; Krill oil; Microbiota

Indexed keywords

MICROORGANISMS; RNA;

16S RRNA; 16S RRNA SEQUENCING; GASTROINTESTINAL TRACT; HIGH-FAT-DIET; HYPERLIPIDEMIA; KRILL OIL; MICROBIAL COMMUNITIES; MICROBIAL COMPOSITION; MICROBIOTAS; OIL TREATMENT;

LOCATION;

BACTERIAL RNA; FISH OIL; KRILL OIL; RNA 16S; SIMVASTATIN; UNCLASSIFIED DRUG; BACTERIAL DNA; BIOLOGICAL PRODUCT; OIL; OMEGA 3 FATTY ACID;

ABUNDANCE; BLOOD SYSTEM DISORDER; COMMUNITY COMPOSITION; COMMUNITY STRUCTURE; CONCENTRATION (COMPOSITION); DIGESTIVE SYSTEM; FECES; MICROBIAL COMMUNITY; MOLECULAR ANALYSIS; OIL; RNA; RODENT; SPECIES DIVERSITY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDETES; CHEMICAL COMPOSITION; COLON; COLON FLORA; CONTROLLED STUDY; DRUG MEGADOSE; EUPHAUSIA SUPERBA; FECES MICROFLORA; FIRMICUTES; FOREGUT; HYPERLIPIDEMIA; ILEUM; INTESTINE FLORA; LIPID DIET; LOW DRUG DOSE; MALE; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MOUSE; NONHUMAN; PROTEOBACTERIA; RNA SEQUENCE; SPECIES RICHNESS; ANATOMY AND HISTOLOGY; ANIMAL; BACTERIUM; CHEMISTRY; CLASSIFICATION; DIETARY SUPPLEMENT; DNA SEQUENCE; DOSE RESPONSE; DRUG EFFECT; FECES; GASTROINTESTINAL TRACT; GENETIC VARIATION; GENETICS; INSTITUTE FOR CANCER RESEARCH MOUSE; ISOLATION AND PURIFICATION; KRILL; MICROBIOLOGY; PHYSIOLOGY; RANDOMIZATION;

EUPHAUSIACEA; MUS; OTUS;

ANIMALS; BACTERIA; BIOLOGICAL PRODUCTS; COLON; DIET, HIGH-FAT; DIETARY SUPPLEMENTS; DNA, BACTERIAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EUPHAUSIACEA; FATTY ACIDS, OMEGA-3; FECES; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GENETIC VARIATION; HYPERLIPIDEMIAS; ILEUM; MALE; MICE; MICE, INBRED ICR; OILS; RANDOM ALLOCATION; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 85032901978     PISSN: 01757598     EISSN: 14320614     Source Type: Journal    
DOI: 10.1007/s00253-017-8601-1     Document Type: Article

References (56)

1. Abliz A, Aji Q, Abdusalam E, Sun X, Abdurahman A, Zhou W, Moore N, Umar A (2014) Effect of Cydonia oblonga mill. Leaf extract on serum lipids and liver function in a rat model of hyperlipidaemia. J Ethnopharmacol 151(2):970–974
2. Aderiye BI, Laleye SA, Odeyemi AT (2007) Hypolipidemic potential of Lactobacillus and Streptococcus sp. from some nigerian fermented foods. Res J Microbiol 2(6):538–544
3. Alessandra F, Annalea C, Lena B, Kjetil B, Francesco DN, Maria GA, Vincenzo Z (2012) A krill oil supplemented diet suppresses hepatic steatosis in high-fat fed rats. PLoS One 7(6):e38797
4. An HM, Park SY, Lee DK, Kim JR, Min KC, Si WL, Lim HT, Kim KJ, Ha NJ (2011) Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids Health Dis 10(1):116
5. Aoki R, Kamikado K, Suda W, Takii H, Mikami Y, Suganuma N (2017) A proliferative probiotic Bifidobacterium strain in the gut ameliorates progression of metabolic disorders via microbiota modulation and acetate elevation. Sci Rep-UK 7:43522
6. Araujo P, Zhu H, Breivik JF, Hjelle JI, Zeng Y (2014) Determination and structural elucidation of triacylglycerols in krill oil by chromatographic techniques. Lipids 49(2):163–172
7. Banni S, Carta G, Murru E, Cordeddu L, Giordano E, Sirigu AR, Berge K, Vik H, Maki KC, Di MV (2011) Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutr Metab 8(1):1–6
8. Bilgin H, Sarmis A, Tigen E, Soyletir G, Mulazimoglu L (2015) Delftia acidovorans: a rare pathogen in immunocompetent and immunocompromised patients. Can J Infect Dis Med Microbiol 26(5):277–279
9. Bindels LB, Segura Munoz RR, Gomesneto JC, Mutemberezi V, Martínez I, Salazar N, Cody EA, Quinterovillegas MI, Kittana H, Cg RG (2017) Resistant starch can improve insulin sensitivity independently of the gut microbiota. Microbiome 5(1):12
10. Burri L, Berge K, Wibrand K, Berge RK, Barger JL (2011) Differential effects of krill oil and fish oil on the hepatic transcriptome in mice. Front Genet 2:45
11. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335
12. Chen H, Miao H, Feng YL, Zhao YY, Lin RC (2014) Metabolomics in dyslipidemia. Adv Clin Chem 66:101
13. Choi JH, Kim GB, Cha CJ (2014) Spatial heterogeneity and stability of bacterial community in the gastrointestinal tracts of broiler chickens. Poultry Sci 93(8):1942–1950
14. Demir O, Sevimli S, Değirmenci H, Duman H, Bakırcı EM, Demirelli S, Hamur H (2013) Evaluation of dose efficacy of treatment with atorvastatin, rosuvastatin and simvastatin in patients with hyperlipidemia. J Am Coll Cardiol 62(18):182
15. Deutsch L (2007) Evaluation of the effect of neptune krill oil on chronic inflammation and arthritic symptoms. J Am Coll Cardiol 26(1):39
16. Drissi F, Merhej V, Angelakis E, Kaoutari AE, Carrière F, Henrissat B, Raoult D (2014) Comparative genomics analysis of Lactobacillus species associated with weight gain or weight protection. Nutr Diabetes 4:e109
17. Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26(19):2460
18. Gu S, Chen D, Zhang JN, Lv X, Wang K, Duan LP, Nie Y (2013) Bacterial community mapping of the mouse gastrointestinal tract. PLoS One 8(10):e74957
19. He K, Hu Y, Ma H, Zou Z, Xiao Y, Yang Y, Feng M, Li X, Ye X (2016) Rhizoma Coptidis alkaloids alleviate hyperlipidemia in B6 mice by modulating gut microbiota and bile acid pathways. BBA-Mol Basis Dis 1862(9):1696–1709
20. Hussein G, Nakagawa T, Goto H, Shimada Y, Matsumoto K, Sankawa U, Watanabe H (2007) Astaxanthin ameliorates features of metabolic syndrome in SHR/NDmcr-cp. Life Sci 80(6):522–529
21. Jenkins DJ, Kendall CW, Vuksan V (1999) Inulin, oligofructose and intestinal function. J Nutr 129(7 Suppl):1431S
22. Jiang X, Takacs-Vesbach CD (2017) Microbial community analysis of pH 4 thermal springs in Yellowstone National Park. Extremophiles Life Under Extreme Conditions 21(1):1–18
23. Khan M, Raoult D, Richet H, Lepidi H, La SB (2007) Growth-promoting effects of single-dose intragastrically administered probiotics in chickens. Br Poult Sci 48(6):732–735
24. Kim CH, Mitchell JB, Bursill CA, Sowers AL, Thetford A, Cook JA, van Reyk DM, Davies MJ (2015) The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE−/− mice. Atherosclerosis 240(1):234–241
25. Kohl KD, Miller AW, Marvin JE, Mackie R, Dearing MD (2014) Herbivorous rodents (Neotoma spp.) harbour abundant and active foregut microbiota. Environ Microbiol 16(9):2869–2878
26. Kreutzer C, Peters S, Schulte DM, Fangmann D, Türk K, Wolff S, Van ET, Ahrens M, Beckmann J, Schafmayer C (2017) Hypothalamic inflammation in human obesity is mediated by environmental and genetic factors. Diabetes. doi:10.2337/db17-0067
27. Lau WB, Ohashi K, Wang Y, Ogawa H, Murohara T, Ma XL, Ouchi N (2017) Role of adipokines in cardiovascular disease. Circ J 81:920–928
28. Le RT, Llopis M, Lepage P, Bruneau A, Rabot S, Bevilacqua C, Martin P, Philippe C, Walker F, Bado A (2013) Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice. Gut 62(12):1787–1794
29. Ley R, Turnbaugh P, Klein S, Gordon J (2006) Human gut microbes associated with obesity. Nature 444(7122):1022–1023
30. Looft T, Allen HK, Cantarel BL, Levine UY, Bayles DO, Alt DP, Henrissat B, Stanton TB (2014) Bacteria, phages and pigs: the effects of in-feed antibiotics on the microbiome at different gut locations. ISME J 8(8):1566
31. Lu C, Sun T, Li Y, Zhang D, Zhou J, Su X (2017a) Modulation of the gut microbiota by krill oil in mice fed a high-sugar high-fat diet. Front Microbiol 8:905. doi:10.3389/fmicb.2017.00905
32. Lu C, Zhou J, Li Y, Zhang D, Wang Z, Cheong L, Zhang C, Su X (2017b) Structural modulation of gut microbiota in Bama minipigs in response to treatment with a “growth-promoting agent”, salbutamol. Appl Microbiol Biotechnol. doi:10.1007/s00253-017-8329-y
33. Marques FZ, Nelson E, Chu PY, Horlock D, Fiedler A, Ziemann M, Tan JK, Kuruppu S, Rajapakse NW, El-Osta A, Mackay CR, Kaye DM (2017) High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation 135(10):964–977
34. Meuric V, Le GDS, Boyer E, Acuñaamador L, Martin B, Fong SB, Barloyhubler F, Bonnauremallet M (2017) Signature of microbial dysbiosis in periodontitis. Appl Environ Microbiol. doi:10.1128/AEM.00462-17
35. Ohkawara S, Furuya H, Nagashima K, Asanuma N, Hino T (2006) Effect of oral administration of Butyrivibrio fibrisolvens MDT-1 on experimental enterocolitis in mice. Clin Vaccine Immunol 13(11):1231–1236
36. Sampalis F, Bunea R, Pelland MF, Kowalski O, Duguet N, Dupuis S (2003) Evaluation of the effects of neptune krill oil on the management of premenstrual syndrome and dysmenorrhea. Altern Med Rev 8(2):171
37. Sato B, Nakajima H, Fujita T, Takase S, Yoshimura S, Kinoshita T, Terano H (2005) FR177391, a new anti-hyperlipidemic agent from Serratia. J Antibiot 58(10):634
38. Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, Lesniewski RA, Oakley BB, Parks DH, Robinson CJ (2009) Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol 75(23):7537–7541
39. Tamburini S, Clemente JC (2016) Zooming in on inflammatory bowel disease: microbial and proteomic features associated with IBD in colonic microenvironments. Cell Mol Gastroen Hepatol 2(5):540–541
40. Tang WH, Kitai T, Hazen SL (2017) Gut microbiota in cardiovascular health and disease. Circ Res 120(7):1183
41. Tomasello G, Tralongo P, Damiani P, Sinagra E, Trapani BD, Zeenny MN, Hussein IH, Jurjus A, Leone A (2014) Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes. World J Gastroentero 20(48):18121–18130
42. Tyler AD, Knox N, Kabakchiev B, Milgrom R, Kirsch R, Cohen Z, McLeod RS, Guttman DS, Krause DO, Silverberg MS (2013) Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis. PLoS One 8(9):e66934
43. Van Horn DJ, Wolf CR, Colman DR, Jiang X, Kohler TJ, Mcknight DM, Stanish LF, Yazzie T, Takacsvesbach CD (2016) Patterns of bacterial biodiversity in the glacial meltwater streams of the McMurdo Dry Valleys, Antarctica. FEMS Microbiol Ecol 92(10):fiw148
44. Wang Q, Garrity GM, Tiedje JM, Cole JR (2007) Naïve bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol 73(16):5261–5267
45. Wirth R, Bódi N, Maróti G, Bagyánszki M, Talapka P, Fekete É, Bagi Z, Kovács KL (2014) Regionally distinct alterations in the composition of the gut microbiota in rats with streptozotocin-induced diabetes. PLoS One 9(12):e110440
46. Wu WK, Panyod S, Ho CT, Kuo CH, Wu MS, Sheen LY (2015) Dietary allicin reduces transformation of L-carnitine to TMAO through impact on gut microbiota. J Funct Foods 15:408–417
47. Xia T, Lai W, Han M, Ma X, Zhang L (2017) Dietary ZnO nanoparticles alters intestinal microbiota and inflammation response in weaned piglets. Oncotarget. 10.18632/oncotarget.17612
48. Xiao L, Si BS, Feng Q, Chen N, Xia Z, Li X, Fang Z, Zhang D, Fjære E, Midtbø LK (2017) High-fat feeding rather than obesity drives taxonomical and functional changes in the gut microbiota in mice. Microbiome 5(1):43
49. Xiao S, Fei N, Pang X, Shen J, Wang L, Zhang B, Zhang M, Zhang X, Zhang C, Li M (2014) A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome. FEMS Microbiol Ecol 87(2):357–367
50. Xu J, Lian F, Zhao L, Zhao Y, Chen X, Zhang X, Guo Y, Zhang C, Zhou Q, Xue Z (2015) Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. ISME J 9(3):552–562
51. Xu X, Zhang X (2015) Lentinula edodes-derived polysaccharide alters the spatial structure of gut microbiota in mice. PLoS One 10(1):e0115037
52. Zhang C (2010) Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J 4(2):232
53. Zhang D, Ji H, Liu H, Wang S, Wang J, Wang Y (2016) Changes in the diversity and composition of gut microbiota of weaned piglets after oral administration of Lactobacillus or an antibiotic. Appl Microbiol Biotechnol 100(23):1–13
54. Zhang X, Zhao Y, Zhang M, Pang X, Xu J, Kang C, Li M, Zhang C, Zhang Z, Zhang Y (2012) Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS One 7(8):e42529
55. Zhao W, Wang Y, Liu S, Huang J, Zhai Z, He C, Ding J, Wang J, Wang H, Fan W (2015) The dynamic distribution of porcine microbiota across different ages and gastrointestinal tract segments. PLoS One 10(2):e0117441
56. Zoetendal EG, Raes J, Arumugam M, Booijink CC, Troost FJ, Bork P, Wels M, de Vos WM, Kleerebezem M (2012) The human small intestinal microbiota is driven by rapid uptake and conversion of simple carbohydrates. ISME J 6(7):1415